Vastus järelepärimisele

Dear Ita,

Thank you for your interest. In 2024, DDD for N05AH02:

Please visit our website  https://ravimiamet.ee/sites/default/files/documents/2025-04/DDD%202024%20ENG.pdf „Estonian Statistics on Medicines 2024“ where you can find the data for all substances.

Best regards,

Marju Sammul

Bureau of Statistics

Department of Post-authorisation Safety

State Agency of Medicines

Estonia

[email protected]

1 Nooruse Street

50411 Tartu

www.ravimiamet.ee

Good afternoon,

I hope you are well. I am part of a research group looking at prescribing rates of clozapine within countries internationally. We are currently looking for data on rates of clozapine prescribing (N05AH02) in Estonia. We have been using reports available on the State Medicines Agency to establish consumption rates. We are looking for 2024 data on rates of clozapine consumption defined as DDD/1,000 inhabitants/day. Is this something you can provide us with?

Best wishes,

Ita

Ita Fitzgerald MPharm, MSc, MPSI, MCMHP, PhD

Advanced Specialist Pharmacist (Mental Health), St. Patrick's University Hospital, James' St., Dublin 8.

Adjunct Clinical Lecturer, School of Pharmacy, University College Cork.

Honorary Clinical Lecturer at the Royal College of Surgeons in Ireland.
01 2493262

This email and any files transmitted with it are confidential and may be privileged and are intended solely for the use of the individual or entity to whom they are addressed. Any unauthorised direct or indirect dissemination, distribution or copying of this message and any attachments is strictly prohibited. Any views or opinions expressed are solely those of the author and do not necessarily represent those of St Patrick’s Mental Health Services. If you have received this email in error, please notify our Data Protection Office by emailing [email protected]. For information about mental health and our services, please visit our website at stpatricks.ie